We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-13.55%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$488M
AUM Growth
-$122M
Cap. Flow
-$46M
Cap. Flow %
-9.42%
Top 10 Hldgs %
12.26%
Holding
885
New
278
Increased
177
Reduced
136
Closed
293

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$7.96M
2
MSFT icon
Microsoft
MSFT
+$6.24M
3
EL icon
Estee Lauder
EL
+$5.96M
4
CSCO icon
Cisco
CSCO
+$5.04M
5
WBA
Walgreens Boots Alliance
WBA
+$4.16M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Consumer Discretionary 16.56%
3 Healthcare 14.16%
4 Industrials 11.69%
5 Consumer Staples 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEYS icon
26
Keysight
KEYS
$53B
$3.02M 0.62%
48,600
-17,900
-27% -$1.08M
TPR icon
27
Tapestry
TPR
$29.6B
$3.01M 0.62%
+89,257
New +$3.59M
GIS icon
28
General Mills
GIS
$19.5B
$2.86M 0.59%
+73,399
New +$3.1M
SBUX icon
29
Starbucks
SBUX
$119B
$2.71M 0.56%
+42,129
New +$2.64M
BIIB icon
30
Biogen
BIIB
$29.8B
$2.71M 0.56%
9,009
+7,700
+588% +$2.46M
CYBR
31
DELISTED
CyberArk
CYBR
$2.69M 0.55%
36,315
+16,800
+86% +$1.2M
ETSY icon
32
Etsy
ETSY
$7.92B
$2.68M 0.55%
56,400
+33,900
+151% +$1.6M
CMG icon
33
Chipotle Mexican Grill
CMG
$42.6B
$2.66M 0.54%
307,950
-335,150
-52% -$3.03M
DXCM icon
34
DexCom
DXCM
$28.5B
$2.64M 0.54%
88,152
-13,200
-13% -$419K
AMED
35
DELISTED
Amedisys
AMED
$2.55M 0.52%
21,788
+8,024
+58% +$946K
TWLO icon
36
Twilio
TWLO
$29.8B
$2.54M 0.52%
28,500
-6,900
-19% -$561K
WP
37
DELISTED
Worldpay, Inc.
WP
$2.33M 0.48%
30,500
+100
+0.3% +$8.7K
NATI
38
DELISTED
National Instruments Corp
NATI
$2.32M 0.47%
+51,043
New +$2.38M
ZBRA icon
39
Zebra Technologies
ZBRA
$12.6B
$2.26M 0.46%
14,200
+1,100
+8% +$183K
MLNX
40
DELISTED
Mellanox Technologies, Ltd.
MLNX
$2.18M 0.45%
+23,640
New +$2.01M
UAL icon
41
United Airlines
UAL
$38.8B
$2.17M 0.44%
25,913
+8,200
+46% +$720K
FXI icon
42
iShares China Large-Cap ETF
FXI
$4.22B
$2.14M 0.44%
+54,800
New +$2.21M
TGT icon
43
Target
TGT
$63.5B
$2.08M 0.43%
+31,500
New +$2.42M
CDNS icon
44
Cadence Design Systems
CDNS
$93.8B
$2.04M 0.42%
46,886
+13,900
+42% +$604K
CSX icon
45
CSX Corp
CSX
$95.3B
$2.04M 0.42%
98,310
-72,690
-43% -$1.67M
UAA icon
46
Under Armour
UAA
$3.02B
$2.03M 0.42%
+115,026
New +$2.36M
AMGN icon
47
Amgen
AMGN
$203B
$1.93M 0.39%
+9,900
New +$1.93M
APH icon
48
Amphenol
APH
$183B
$1.93M 0.39%
95,140
+68,800
+261% +$1.48M
FFIV icon
49
F5
FFIV
$22.6B
$1.88M 0.38%
+11,600
New +$1.99M
TMO icon
50
Thermo Fisher Scientific
TMO
$209B
$1.88M 0.38%
+8,400
New +$1.97M

Similar funds

Bayesian Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Bayesian Capital Management held 885 positions worth $488M, down 20% from $611M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $46M in Q4 2018, closing 293 positions and reducing 136 holdings. Its most notable exit was Lowe's Companies, an estimated $6.56M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Nike worth $7.89M.

  • Bayesian Capital Management's largest Q4 2018 buy was Nike: 106,400 shares worth $7.89M.
  • Bayesian Capital Management added most to Microsoft in Q4 2018, an estimated $6.24M increase.
  • Bayesian Capital Management's biggest Q4 2018 reduction was lululemon athletica, cutting an estimated $6.86M.
  • Bayesian Capital Management fully exited Lowe's Companies in Q4 2018, selling an estimated $6.56M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $488M portfolio in Q4 2018.
  • Bayesian Capital Management opened 278 new positions and closed 293 in Q4 2018.
  • Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $488M.

Based on Bayesian Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.